Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation
Published inPediatric transplantation, vol. 16, no. 2, p. 131-136
Publication date2012
Abstract
Keywords
- Anemia, Aplastic/surgery
- Child
- Fatal Outcome
- Female
- Graft vs Host Disease/etiology/surgery
- Hematopoietic Stem Cell Transplantation
- Humans
- Mesenchymal Stromal Cells/transplantation
- Postoperative Complications/surgery
- Renal Insufficiency/etiology/surgery
- Thrombotic Microangiopathies/etiology/surgery
Citation (ISO format)
ANSARI DJABERI, Marc Georges et al. Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantation. In: Pediatric transplantation, 2012, vol. 16, n° 2, p. 131–136. doi: 10.1111/j.1399-3046.2011.01621.x
Main files (1)
Article (Published version)
Identifiers
- PID : unige:25167
- DOI : 10.1111/j.1399-3046.2011.01621.x
- PMID : 22151234
ISSN of the journal1397-3142